Conferences \ Next Generation Sequencing in the Clinic Asia Summit 2017 \ Agenda \ Jing Chen |
Register | Login |
Detection of Previously Unidentified Structural Variants Involved in Glioblastoma Using PacBio® Sequel™ SequencingThursday, 30 November 2017 at 15:00 Add to Calendar ▼2017-11-30 15:00:002017-11-30 16:00:00Europe/LondonDetection of Previously Unidentified Structural Variants Involved in Glioblastoma Using PacBio® Sequel™ SequencingNext Generation Sequencing in the Clinic Asia Summit 2017 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com Glioblastoma is a devastating disease due in part to its often late-stage diagnosis, rapid progression, and poor survival rates. This casestudy looks at how GENEWIZ utilized the PacBio® Sequel™ long-read technology to help a customer improve detection of structural variants within glioblastoma samples.
|